News Archives

News Archives

Avivagen and Mimi’s Rock Announce Joint Venture for the Companion Animal Market

State of the art e-commerce platform to offer exclusive products for the pet market Ottawa, ON and Toronto, ON / Business Wire / June 13, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), owner of the intellectual property protected OxC-beta™ technology that supports the optimal health of companion animals, and Mimi’s Rock Corp. …Read More

Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2019

An increase of 73% in sales over the six-month period Ottawa, ON /Business Wire/ June 4, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a world leader in natural alternatives to antibiotics with its OXC-beta™ technology, reported today its unaudited financial results for the second quarter of 2019 and Stock Option plan update. …Read More

Avivagen Announces Officer Changes

Ottawa, ON / Business Wire / May 14, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces the appointments of Mr. Kym Anthony to the position …Read More

Avivagen Press Release Correction

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Ottawa, ON/Business Wire/April 12, 2019/Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human …Read More

Avivagen Announces Results From Its Annual General Meeting April 10, 2019

Ottawa, ON / Business Wire / April 11, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that at the Corporation’s Annual General Meeting (AGM) held …Read More

Avivagen Continues Expansion with an Order from a New Market in Asia

 Ottawa, ON /Business Wire/ April 10, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, is pleased to announce that it has received a new purchase order for its OxC-beta™ Livestock product.  This order represents a new customer in a new jurisdiction and …Read More